ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,881.30
1.65%
S&P ASX All Technology
3,109.60
1.94%
Brent Oil
83.09
0.53%
US Dollar vs AUD
1.49817
0.36%
Bitcoin
66,088.51
-0.26%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Structure Therapeutics Inc (GPCR)

  7. Structure Therapeutics Inc (GPCR) News

GPCR Structure Therapeutics Inc

36.33
0.26 (0.72%)
Last Updated: 00:30:23
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Structure Therapeutics Inc GPCR NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.26 0.72% 36.33 00:30:23
Open Price Low Price High Price Close Price Previous Close
35.99 35.44 36.48 36.07
more quote information »

Recent News

Date Time Source Heading
10/5/202406:56EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202406:10EDGAR2Form 8-K - Current report
10/5/202406:05GLOBEStructure Therapeutics Reports First Quarter 2024 Financial..
09/3/202408:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/3/202408:05GLOBEStructure Therapeutics to Present at Leerink Partners Global..
09/3/202401:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
09/3/202400:43EDGAR2Form 8-K - Current report
09/3/202400:30GLOBEStructure Therapeutics Reports Fourth Quarter and Full Year..
19/12/202300:28EDGAR2Form 8-K - Current report
18/12/202323:30GLOBEStructure Therapeutics Provides Comprehensive GSBR-1290..
30/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
18/11/202309:25EDGAR2Form S-1 - General form for registration of securities under..
18/11/202308:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18/11/202308:51EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
17/11/202309:13EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
15/11/202308:10GLOBEStructure Therapeutics Reports Third Quarter 2023 Financial..
29/9/202321:50EDGAR2Form 8-K - Current report
29/9/202321:38EDGAR2Form 8-K - Current report
29/9/202321:32GLOBEStructure Therapeutics Announces $300 Million Private..
29/9/202321:30GLOBEStructure Therapeutics Announces Positive Results from Phase..
11/8/202306:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:19EDGAR2Form 8-K - Current report
11/8/202306:05GLOBEStructure Therapeutics Reports Second Quarter 2023 Financial..
05/8/202306:30EDGAR2Form 8-K - Current report
04/8/202307:32GLOBEStructure Therapeutics Appoints Ted W. Love, M.D., to Board..
07/7/202306:05EDGAR2Form 8-K - Current report
07/6/202322:30GLOBEStructure Therapeutics Announces Poster Presentations of its..
01/6/202306:30GLOBEStructure Therapeutics to Present at Jefferies Healthcare..
26/5/202306:30GLOBEStructure Therapeutics Initiates Phase 2a Study of Oral..
19/5/202306:30GLOBEStructure Therapeutics Announces Poster Presentations at the..

Your Recent History

NASDAQ
GPCR
Structure Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved